A comparative study on the pain control effect and safety of a local area pain control device (On-Q® or PainBuster®) compared to a conventional intravenous injection patient control analgesic device (PCA) in a pregnant woman undergoing cesarean section.

Investigation of effects of use of the On-Q? PainBuster? Pain Pump on pain-control and opioid level of serum in women with Cesarean section

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0005108

Enrollment

Registered

2020-06-11

Start date

2020-08-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In the test group, 200 cc of ropivacaine 0.75% concentration was injected into the On-Q pump, and 200 cc of physiological saline was injected into the control group.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) women planning to get the cesarean section delivery 2) women who can read and understand the Korean. 3) women without the exclusion criteria 4) women giving informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria : 1) A person who has allergic reaction to the bupivacaine 2) Drug addicts or alcoholics 3) A person with a history of mental illness 4) Serum Creatinine > 2mg/dL

Design outcomes

Primary

Measure	Time frame
pain scaling score	—

Secondary

Measure	Time frame
fentanyl concentration	—

Countries

Korea, Republic of

Contacts

Public ContactYeonhee Kim

The Catholic University of Korea, Uijeongbu St. Mary’s Hospital

yoni7727g@gmail.com+82-31-820-3579

Outcome results